期刊文献+

不典型过敏性支气管肺曲霉病1例 被引量:1

下载PDF
导出
摘要 过敏性支气管肺曲霉病(ABPA)又称变应性支气管肺曲霉病,症状主要有发热、咳嗽、气急、喘息和咳棕色痰栓等。实验室检查痰培养可见曲霉、血清总Ig E明显升高、血嗜酸性粒细胞升高、烟曲霉皮试速发阳性等。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2016年第2期453-455,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金青年项目(81302934) 浙江省科技厅钱江人才计划(2012R10063) 浙江省卫生厅医药卫生科技计划项目(2013KYA140)
  • 相关文献

参考文献7

  • 1Kaur M,Sudan DS.Allergic Bronchopulmonary Aspergillosis(ABPA)-The High Resolution Computed Tomography(HRCT)Chest Imaging Scenario[J].J Clin Diagn Res,2014;8(6):RC05.
  • 2Jat KR,Walia DK,Khairwa A.Anti-Ig E therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis[J].Cochrane Database Syst Rev,2015;11:CD010288.
  • 3Lazarus AA,Thilagar B,Mc Kay SA.Allergic bronchopulmonary aspergillosis[J].Dis Mon,2008;54(8):547-64.
  • 4陈灏珠,丁训杰,廖履坦,等.实用内科学[M].北京:人民卫生出版社,2013:1556.
  • 5Shah A,Panjabi C.Allergic aspergillosis of the respiratory tract[J].Eur Respirat Rev,2014;23(131):8-29.
  • 6Moreira AS,Silva D,Ferreira AR,et al.Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis:a systematic review[J].Clin Exp Allergy,2014;44(10):1210-27.
  • 7孙康悦,陈晓红.奥马珠单抗治疗过敏性疾病及其相关进展[J].中国药房,2014,25(22):2083-2085. 被引量:5

二级参考文献16

  • 1刘长智,郑晓滨,刘茂,等.奥马珠单抗治疗难治性哮喘疗效与安全性的Meta分析[J].中华临床医师杂志:电子版,2013.7(14):6519.
  • 2Lanier B, Bridges T, Kulus M, et al. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma[J]. J Allergy Clin lmmunol, 2009,124(6) : 1 210.
  • 3Busse WW, Morgan WJ, Gergen P J, et al. Randomized tri- al of omalizumab (anti-IgE) for asthma in inner-city chil- dren[J]. NEnglJMed, 2011,364(11) : 1 005.
  • 4Hanania NA, Alpan O, Hamilos DL, et al.Omalizumab in severe allergic asthma inadequately controlled with stan- dard therapy: a randomized trial[J].Ann lntern Med, 2011, 154(9):573.
  • 5Casale TB, Condemi J, LaForce C, et al. Effect of omali- zumab on symptoms of seasonal allergic rhinitis: a ran- domized controlled trial[J]. JAM_A, 2001,286(23) :2 956.
  • 6Chervinsky P, Casale T, Townley R, et aL Omalizumab, an anti-IgE antibody,, in the treatment of adults and ado- lescents with perennial allergic rhinitis[J]. Ann Allergy Asthma lmmunol, 2003,91 ( 2 ) : 160.
  • 7Spector SL, Tan RA. Effect of omalizumab on patients with chronic urticaria[J]. Ann Allergy Asthma lmmunol, 2007, 99(2):190.
  • 8Kaplan AP, Joseph K, Maykut ILl, et al. Treatment of chron- ic autoimmune urticaria with omalizumab[J]. J Allergy Clin Immunol, 2008,122 ( 3 ) : 569.
  • 9Maurer M, Ros6n K, Hsieh H J, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticar- ia[J]. NEnglJMed, 2013,368(10) :924.
  • 10Belloni B, Ziai M, Lim A, et al. Low-dose anti-IgE thera- py in patients with atopic eczema with high serum IgE lev- els [J]. JAllergy Clinlmmunol,2007,120(5):1 223.

共引文献88

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部